Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer
Status:
Terminated
Trial end date:
2019-03-13
Target enrollment:
Participant gender:
Summary
External beam photon stereotactic body radiotherapy (SBRT) using a linear accelerator to a
total dose of 40 Gy in 5 fractions delivered once daily with at least 48 hours between each
fraction. SBRT treatment will be completed within a 21-day window. Starting within 14 days
after completion of SBRT, intravenous nivolumab 240 mg will be given every 2 weeks as
monotherapy or in combination with ipilimumab 1 mg/kg IV every 6 weeks.